Method for preventing blood coaguli from being formed in the extra-body circuit of dialysis apparatus and composition useful therefor

• US 4,938,873 A
• Filed: 10/24/1988
• Issued: 07/03/1990
• Est. Priority Date: 10/23/1987
• Status: Expired due to Fees

• Current Assignee: Crinos Industria Farmacobiologics S.p.A.
• Original Assignee: Crinos Industria Farmacobiologics S.p.A.
• Inventors: Rossi, Renato
• Primary Examiner(s): Jones, W. Gary
• Application Number:
  US07/261,539
• Time in Patent Office: 617 Days
• Field of Search: 210/644, 210/645, 210/646, 210/647, 604/4, 604/5, 604/6
• US Class Current: 210/646
• CPC Class Codes: A61K 31/70 Carbohydrates; Sugars; Derivatives thereof sorbitol A61K31/047
• CPC Class Codes: A61M 1/3672 Means preventing coagulation
• CPC Class Codes: A61M 1/3675 Deactivation

Abstract

The introduction of Defibrotide, as a bolus or by infusion, upstream of the dialysis membrane of the extra body circuit of apparatus for the extra-body dialysis prevents coaguli from being formed in the blood stream.

Claims

1. A method for preventing the formation of blood coaguli in an extracorporeal hemodialysis apparatus, said apparatus comprising a first means for transporting blood from a patient to a dialyzer, a hemodialysis membrane for dialyzing the blood transported thereto, and a second means for returning the dialyzed blood to the patient, which comprises introducing defibrotide into the blood in said first means upstream of the dialyzer in an amount effective to prevent the formation of blood coaguli in said apparatus.

2. A method according to claim 1, wherein the amount of defibrotide introduced is at least 200 mg.

3. A method according to claim 1, wherein the defibrotide is administered in a single dose.

4. A method according to claim 1, wherein the defibrotide is introduced at intervals.

5. A method according to claim 1, wherein the defibrotide is introduced by continuous infusion.

6. A method according to claim 5, wherein the amount of defibrotide introduced is at least 500 mg.

7. A method according to claim 6, wherein the amount of the defibrotide introduced is 600-800 mg.

8. A method according to claim 1, wherein the hemodialysis apparatus includes a pump for circulating blood through said apparatus and the defibrotide is introduced upstream of the pump.